PATENT CLAIM ANALYSIS

Application Number: 15879272
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "461000"]

Abstract:
The invention relates to extended release pharmaceutical formulations in form of multiparticulates comprising 40-O-(2-hydroxy)ethyl-rapamycin, to dosage forms which comprise said pharmaceutical formulations, to methods of preparing said pharmaceutical formulations and said dosage forms, to uses of said pharmaceutical formulations and said dosage for the manufacture of a medicament for the treatment or prevention of diseases or conditions responsive to inhibition of mTOR signaling pathway, such as for instance proliferative diseases or immunosuppression.

Claim (Index 2):
An extended release pharmaceutical formulation for oral administration in form of a multiparticulate according to  claim 1 , wherein the extended release coating further comprises a pore former.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.65306
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13073677', '11774109', '12512701', '11930644', '14841428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7517137303973095
- 35 USC 102 Novelty (BERT): 0.5011722447032558
- Combined Prediction Score: 0.7266595818279041
- Mean Citation Score: 247.651794
- Max Citation Score: 255.85129
- Similarity Product: 186.9805230552328

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test